“…Coronavirus disease 2019 (COVID-19) is a complex disorder caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and affects many bodily functions, including excessive immunological response, autoimmunity, and endothelial dysfunction, that have been implicated in the risk of thrombotic events and coagulopathies. − While the acute phase of COVID-19 primarily manifests as a respiratory illness, with a wide range of symptoms including fever, headache, cough, fatigue, muscle pain, and shortness of breath, more severe clinical symptoms, such as systemic inflammatory response syndrome (SIRS), acute respiratory disease syndrome (ARDS), and neurological and cardiovascular complications, have been associated with processes underlying coagulopathies and endotheliopathies. ,, Currently, it is estimated that approximately 30% of individuals with COVID-19 continue to suffer from a variety of different symptoms involving specific or multiple organ systems, with neurological, neuropsychiatric, and cardiorespiratory clinical presentations, , a condition known as postacute sequelae of COVID (PASC) or long COVID. ,, Fatigue, cough, dyspnea, chest pain, headache, dizziness, cognitive impairment known as “brain fog”, and long-term smell and taste dysfunction are the most commonly reported symptoms in individuals suffering from long COVID. ,, The World Health Organization defines long COVID as a condition in which individuals with a probable or confirmed infection with SARS-CoV-2 still experience COVID-19-related symptoms usually three months postinfection and lasting for at least two months, with no alternative diagnosis . Endotheliopathy, coagulopathy, and thrombosis are also now established complications of COVID-19 and can persist in individuals diagnosed with long COVID, contributing to the pathogenesis and clinical manifestations of these conditions. ,− …”